Global Product Manager and Group Leader Marketing Immunology
BIOGRAPHY
OCT 07, 2021 8:00 AM PDT
SARS-CoV-2 specific B cell detection and therapeutic antibody discovery
Speaker
Event Date & Time
Date: October 7, 2021
Time: 8:00am (PDT), 11:00am (EDT)
Abstract
To combat the COVID-19 pandemic, comprehensive characterization of humoral and cellular immune responses to SARS-CoV-2 is essential. At Miltenyi Biotec, we have developed reliable tools and methods for analyzing and enriching rare populations of SARS-CoV-2-specific B cells. Learn how our products and protocols facilitate COVID-19 research, and support the discovery and development of therapeutic antibodies against SARS-CoV-2 and other diseases.
Learning Objectives
- Discuss and understand how antigen specific lymphocytes work together against SARS-CoV-2
- Describe tools and protocols for monitoring and researching on SARS-CoV-2 specific B cells
- Provide an overview on the generation of monoclonal antibodies from antigen-specific B cells
Webinars will be available for unlimited on-demand viewing after live event.
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
Loading Comments...